Phaxiam Therapeutics Quote - 0QSS

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

71.025

Bid

6.925

Offer

7.28

Volume

0.00

0.00 Day's Range 0.00

71.025 52 Week Range 71.025

Market Cap

431.477M

Previous Close

71.025

Open

Last Trade

(O)

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

6,075,000

Dividend Yield

PE Ratio

-0.44

Earnings Per Share (EPS)

-3.87

Revenue

1.33M

Net Profit

-23.49M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.phaxiam.com

Headquarters

Lyon, Rhone, Fra

Founded

Phaxiam Therapeutics is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0QSS. The last closing price for Phaxiam Therapeutics was 71.03 €. Over the last year, Phaxiam Therapeutics shares have traded in a share price range of 71.025 € to 71.025 €.

Phaxiam Therapeutics currently has 6,075,000 shares in issue. The market capitalisation of Phaxiam Therapeutics is 431.48 € million. Phaxiam Therapeutics has a price to earnings ratio (PE ratio) of -0.44.

PHAXIAM Therapeutics : information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 29 novembre 2024

PHAXIAM Therapeutics : information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 29 novembre 2024 Article 223-16 du Règlement Général de...

PHAXIAM Therapeutics : monthly information related to total number of voting rights and shares composing the share capital – November 29, 2024

PHAXIAM Therapeutics : monthly information related to total number of voting rights and shares composing the share capital – November 29, 2024 Article 223-16 of general regulation of French...

PHAXIAM présente une stratégie de développement ambitieuse pour tirer parti de l'évolution rapide du marché de la phagothérapie

PHAXIAM présente une stratégie de développement ambitieuse pour tirer parti de l'évolution rapide du marché de la phagothérapie Tenue d’un webinaire le 27 novembre 2024 « Evolving strategic...

PHAXIAM Therapeutics presents an ambitious development strategy to take advantage of the rapidly evolving Phages therapy area

PHAXIAM Therapeutics presents an ambitious development strategy to take advantage of the rapidly evolving Phages therapy area Webinar being held today "Evolving strategic context for phages...

PHAXIAM a présenté son test IVD Phagogramme et l’actualisation du suivi de sensibilité à ses phages lors du premier « Phagogram Day »

PHAXIAM a présenté son test IVD Phagogramme et l’actualisation du suivi de sensibilité à ses phages lors du premier « Phagogram Day » PHAXIAM a présenté son test IVD Phagogramme et l’actualisation...

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 octobre 2024

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social au 31 octobre 2024 Information mensuelle relative au nombre total de droits de vote et...

Period	Open	High	Low	Avg. Daily Vol	VWAP
1	71.025	71.025	71.025	4	71.025	DE
4	71.025	71.025	71.025	1	71.025	DE
12	71.025	71.025	71.025	5	71.025	DE
26	71.025	71.025	71.025	3	71.025	DE
52	71.025	71.025	71.025	3	71.025	DE
156	71.025	71.025	71.025	1494	71.025	DE
260	71.025	71.025	71.025	1945	71.025	DE

0QSS - Frequently Asked Questions (FAQ)

What is the current Phaxiam Therapeutics share price?

The current share price of Phaxiam Therapeutics is 71.025 €

How many Phaxiam Therapeutics shares are in issue?

Phaxiam Therapeutics has 6,075,000 shares in issue

What is the market cap of Phaxiam Therapeutics?

The market capitalisation of Phaxiam Therapeutics is EUR 431.48M

What is the 1 year trading range for Phaxiam Therapeutics share price?

Phaxiam Therapeutics has traded in the range of 71.025 € to 71.025 € during the past year

What is the PE ratio of Phaxiam Therapeutics?

The price to earnings ratio of Phaxiam Therapeutics is -0.44

What is the cash to sales ratio of Phaxiam Therapeutics?

The cash to sales ratio of Phaxiam Therapeutics is 7.83

What is the reporting currency for Phaxiam Therapeutics?

Phaxiam Therapeutics reports financial results in EUR

What is the latest annual turnover for Phaxiam Therapeutics?

The latest annual turnover of Phaxiam Therapeutics is EUR 1.33M

What is the latest annual profit for Phaxiam Therapeutics?

The latest annual profit of Phaxiam Therapeutics is EUR -23.49M

What is the registered address of Phaxiam Therapeutics?

The registered address for Phaxiam Therapeutics is 60 AVENUE ROCKEFELLER, LYON, RHONE, 69008

What is the Phaxiam Therapeutics website address?

The website address for Phaxiam Therapeutics is www.phaxiam.com

Which industry sector does Phaxiam Therapeutics operate in?

Phaxiam Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
SCGLSealand Capital Galaxy Limited	3.25p (103.13%)	12.18M
BORBorders & Southern Petroleum Plc	3.64p (51.04%)	23.81M
NEONeo Energy Metals Plc	0.95p (22.58%)	37.84M
GNIPGenip Plc	32.00p (20.75%)	192.82k
ZIOCZanaga Iron Ore Company Limited	10.50p (19.86%)	2.84M
DGIDg Innovate Plc	0.02p (-20.00%)	298.54M
SNGSynairgen Plc	2.10p (-19.39%)	1.67M
VRSVersarien Plc	0.03p (-18.92%)	103.72M
QEDQuadrise Plc	5.90p (-17.83%)	17.66M
ZENZenith Energy Ltd.	4.90p (-16.24%)	1.48M
SYMESupply@me Capital Plc	0.0042p (12.00%)	1.19B
MSMNMosman Oil And Gas Limited	0.035p (12.90%)	654.48M
TRPTower Resources Plc	0.0395p (0.00%)	570.56M
CPXCap-xx Limited	0.1775p (-2.74%)	379.2M
NTVONativo Resources Plc	0.0019p (-5.00%)	312.89M